| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 74 |
| 1 | ZOLEDRONIC ACID | 73 |
| 2 | ALENDRONATE SODIUM | 57 |
| 3 | PAMIDRONATE DISODIUM | 52 |
| 4 | THALIDOMIDE | 36 |
| 5 | LETROZOLE | 33 |
| 6 | ANASTROZOLE | 32 |
| 7 | CAPECITABINE | 28 |
| 8 | PREDNISONE | 27 |
| 9 | DEXAMETHASONE | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAMIDRONATE DISODIUM | 52 | 0.0153 |
| 1 | TOREMIFENE CITRATE | 3 | 0.0070 |
| 2 | NAFARELIN ACETATE | 1 | 0.0037 |
| 3 | TAMOXIFEN CITRATE | 13 | 0.0022 |
| 4 | FLUTAMIDE | 2 | 0.0020 |
| 5 | ZOLEDRONIC ACID | 73 | 0.0018 |
| 6 | EPOETIN ALFA | 16 | 0.0014 |
| 7 | VINORELBINE | 8 | 0.0011 |
| 8 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 9 | EXEMESTANE | 23 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 80 |
| 1 | RANK Ligand Inhibitor [EPC] | 74 |
| 2 | Aromatase Inhibitor [EPC] | 72 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 37 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 24 |
| 6 | Loop Diuretic [EPC] | 23 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 21 |
| 8 | Opioid Agonist [EPC] | 20 |
| 9 | Benzodiazepine [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 1 | Aromatase Inhibitor [EPC] | 72 | 0.0006 |
| 2 | Estrogen Receptor Antagonist [EPC] | 16 | 0.0004 |
| 3 | RANK Ligand Inhibitor [EPC] | 74 | 0.0004 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 24 | 0.0003 |
| 5 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 6 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 7 | Androgen Receptor Inhibitor [EPC] | 14 | 0.0002 |
| 8 | Stimulant Laxative [EPC] | 2 | 0.0001 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 37 | 0.0001 |